An erythroid-specific chromatin opening element reorganizes β-globin promoter chromatin structure and augments gene expression

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 4, 2001, Pages 767-780

  Nemeth, M J ^a   Bodine, D M ^b   Garrett, L J ^c   Lowrey, C H ^a,d  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DEOXYRIBONUCLEASE I;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEOXYRIBONUCLEASE I HYPERSENSITIVE SITE; ENHANCER REGION; ENZYME STRUCTURE; FETUS LIVER; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; TRANSGENIC MOUSE;

EID: 0034748441     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0448     Document Type: Article

References (47)

1. Chromosomal subunits in active genes have an altered conformation
2. Beta-globin gene inactivation by DNA translocation in γβ-thalassemia
3. A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire betaglobin locus
4. Human fetal to adult hemoglobin switching: Changes in chromatin structure of the β-globin gene locus
5. The "beta-like-globin" gene domain in human erythroid cells
6. Erythroid-specific nuclease-hypersensitive sites flanking the human β-globin domain
7. Evidence for a locus activation region: The formation of developmentally-stable hypersensitive sites in globin expressing hybrids
8. The locus control region is necessary for gene expression in the human betaglobin locus but not the maintenance of an open chromatin structure in erythroid cells
9. Position-independent, high-level expression of the human beta-globin gene in transgenic mice
10. γδβ thalassemia due to a de novo mutation deleting the 5′β-globin gene activation region hypersensitive sites
11. A distant gene deletion affects β-globin in an atypical γδβ thalassemia
12. Chromatin as an essential part of the transcriptional mechanism
13. Synergistic regulation of human beta-globin gene switching by locus control region elements HS3 and HS4
14. Chromatin structure of transcriptionally active genes
15. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5′ hypersensitive site 2 of the beta-globin locus control region
16. Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin
17. An enhancer/locus control region is not sufficient to open chromatin
18. Nuclear localization and histone acetylation: A pathway for chromatin opening and transcriptional activation of the human beta-globin locus
19. Acetylation of a specific promoter nucleosome accompanies activation of the epsilon-globin gene by beta-globin locus control region HS2
20. The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus
21. Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region
22. Mechanism of DNase I hypersensitive site formation within the human globin locus control region
23. Hypersensitive site 4 of the human beta globin locus control region
24. Locus control regions of mammalian beta-globin gene clusters: Combining phylogenetic analyses and experimental results to gain functional insights
25. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region
26. Conserved elements containing NF-E2 and tandem GATA binding sites are required for erythroid-specific chromatin structure reorganization within the human beta-globin locus control region
27. Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression
28. Detailed analysis of the site 3 region of the human beta-globin dominant control region
29. The beta-globin dominant control region: Hypersensitive site 21
30. The minimal requirements for activity in transgenic mice of hypersensitive site 3 of the beta globin locus control region
31. Developmental specificity of the interaction between the locus control region and embryonic or fetal globin genes in transgenic mice with an HS3 core deletion
32. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing
33. A 36-base-pair core sequence of locus control region enhances retrovirally transferred human beta-globin gene expression
34. Position independence and proper developmental control of gamma-globin gene expression require both a 5′ locus control region and a downstream sequence element
35. Rapid reprogramming of globin gene expression in transient heterokaryons
36. TBP binding and the rate of transcription initiation from the human β-globin gene
37. A directly repeated sequence in the β-globin promoter regulates transcription in murine erythroleukemia cells
38. Nucleosome positioning and gene regulation
39. Developmentally stable chromatin structure in the human beta-globin gene cluster
40. Identification of cis-acting elements as DNase I hypersensitive sites in lysozyme gene chromatin
41. Restriction enzymes permit quantitative determination of defined chromatin structures within the chromosome
42. Dual promoter activation by the human beta-globin locus control region
43. Comparison of expression of human globin genes transferred into mouse erythroleukemia cells and in transgenic mice
44. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators
45. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription
46. An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like" globin genes